Results 111 to 120 of about 70,211 (203)

Tamoxifen-resistant breast carcinoma xenograft [PDF]

Breast Cancer Research, 2000
openaire   +1 more source

Involvement of RFC3 in tamoxifen resistance in ER-positive breast cancer through the cell cycle. [PDF]

Aging (Albany NY), 2023
Zhu J, Ye L, Sun S, Yuan J, Huang J, Zeng Z.   +5 more
europepmc   +1 more source

The role of mitochondrial/metabolic axis in development of tamoxifen resistance in breast cancer. [PDF]

Hum Cell, 2023
Azzam HN, El-Derany MO, Wahdan SA, Faheim RM, Helal GK, El-Demerdash E.   +5 more
europepmc   +1 more source

Inhibition of Increased Invasiveness of Breast Cancer Cells With Acquired Tamoxifen Resistance by Suppression of CYR61. [PDF]

Cancer Genomics Proteomics, 2023
Bauerschmitz G, Hüchel S, Gallwas J, Gründker C.   +3 more
europepmc   +1 more source

Stromal-epithelial interactions and tamoxifen resistance

, 2007
Fil: Simian, Marina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "dr.angel Roffo". Departamento de Radioterapia y Cancer Experimental; Argentina.
Pontiggia, Osvaldo Alejandro, Fiszman, Gabriel Leon, Rodriguez, Vanina, Bal, Elisa Dora, Simian, Marina   +4 more
openaire   +1 more source

ELOVL2-AS1 suppresses tamoxifen resistance by sponging miR-1233-3p in breast cancer. [PDF]

Epigenetics, 2023
Kim HW, Baek M, Jung S, Jang S, Lee H, Yang SH, Kwak BS, Kim SJ.   +7 more
europepmc   +1 more source

FOXA2 as a SETD1A-Regulated Driver of Tamoxifen Resistance in Breast Cancer. [PDF]

Oncol Res
Kim MR, Lee JR, Zhang X, Jeong KW.
europepmc   +1 more source

RelB-activated GPX4 inhibits ferroptosis and confers tamoxifen resistance in breast cancer. [PDF]

Redox Biol, 2023
Xu Z, Wang X, Sun W, Xu F, Kou H, Hu W, Zhang Y, Jiang Q, Tang J, Xu Y.   +9 more
europepmc   +1 more source

STAMBP Accelerates Progression and Tamoxifen Resistance of Breast Cancer Through Deubiquitinating ERα. [PDF]

Biomolecules
Wang Z, Gu L, Yang M, Zhou Y, Qin X, Xiong C.   +5 more
europepmc   +1 more source

BMP1 Appears to be Involved in GPER1-mediated Progression and Tamoxifen Resistance of Luminal A Breast Cancer Cells. [PDF]

Cancer Genomics Proteomics
Wert K, Jentsch J, Gallwas J, Gründker C.   +3 more
europepmc   +1 more source